- Report
- April 2025
- 44 Pages
United States
- Report
- February 2025
- 218 Pages
Global
From €4231EUR$4,799USD£3,690GBP
- Report
- August 2025
- 154 Pages
Global
From €2336EUR$2,650USD£2,037GBP
- Report
- June 2025
- 379 Pages
Global
From €4364EUR$4,950USD£3,806GBP
- Report
- June 2025
- 151 Pages
Global
From €2314EUR$2,625USD£2,018GBP
€3086EUR$3,500USD£2,691GBP
- Report
- February 2025
- 153 Pages
Global
From €5246EUR$5,950USD£4,575GBP
- Report
- April 2025
- 100 Pages
Global
From €5246EUR$5,950USD£4,575GBP
- Report
- April 2025
- 147 Pages
Global
From €2247EUR$2,549USD£1,960GBP
€2644EUR$2,999USD£2,306GBP
- Report
- March 2025
- 149 Pages
Global
From €2247EUR$2,549USD£1,960GBP
€2644EUR$2,999USD£2,306GBP
- Report
- January 2025
- 132 Pages
Global
From €2247EUR$2,549USD£1,960GBP
€2644EUR$2,999USD£2,306GBP
- Report
- November 2025
- 150 Pages
Global
From €5246EUR$5,950USD£4,575GBP
- Report
- November 2025
- 182 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- November 2025
- 195 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- November 2025
- 194 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- November 2025
- 188 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- November 2025
- 199 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- November 2025
- 193 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- November 2025
- 191 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- October 2025
- 196 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP
- Report
- October 2025
- 189 Pages
Global
From €3126EUR$3,545USD£2,726GBP
€3473EUR$3,939USD£3,029GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more